Effects of different test conditions on MICS of food animal growth- promoting antibacterial agents for Enterococci

Journal of Clinical Microbiology

Volumn 36, Issue 7, 1998, Pages 1907-1911

  Butaye, Patrick ^a   Devriese, Luc A ^a   Haesebrouck, Freddy ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AVILAMYCIN; AVOPARCIN; BACITRACIN; NARASIN; TYLOSIN; UNCLASSIFIED DRUG; VIRGINIAMYCIN;

ANAEROBIC METABOLISM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL METABOLISM; BACTERIUM CULTURE; CULTURE MEDIUM; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; ENTEROCOCCUS HIRAE; ENTEROCOCCUS MUNDTII;

EID: 0031864374     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.7.1907-1911.1998     Document Type: Article

References (22)

1. Bates, J., J. Z. Jordans, and D. T. Griffiths. 1994. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J. Antimicroh. Chemother. 34:507-514.
2. Buschelman, B. J., R. N. Jones, and M. B. Bale. 1994. Effects of blood medium supplementation on activities of newer cephalosporins tested against enterococci. J. Clin. Microbiol. 32:565-567.
3. Devriese, L. A., M. D. Collins, and R. Wirth. 1991. The genus Enterococcus, p. 1465-1481. In A. Balows, H. G. Trüper, M. Dworkin, W. Harder, and K.-H. Schleifer (ed.), The prokaryotes, vol. II, 2nd ed. Springer-Verlag, New York, N.Y.
4. Devriese, L. A., K. Ceyssens, and F. Haesebrouck. 1991. Characteristics of Enterococcus cecorum strains from the intestines of different animal species. Lett. Appl. Microbiol. 12:137-139.
5. Devriese, L. A., B. Pot, and M. D. Collins. 1993. Phenotypic identification of the genus Enterococcus and differentiation of phylogenetically distinct enterococcal species and species groups. J. Appl. Bacteriol. 75:399-408.
6. Dutta, G. N., and L. A. Devriese. 1982. Susceptibility of fecal streptococci of poultry origin to nine growth-promoting agents. Appl. Environ. Microbiol. 44:832-837.
7. Dutta, G. N., and L. A. Devriese. 1984. Observations on the in vitro sensitivity and resistance of Gram positive intestinal bacteria of farm animals to growth promoting antimicrobial agents. J. Appl. Bacteriol. 56:117-123.
8. Evers, S., R. Quintiliani, and P. Courvalin. 1996. Genetics of resistance in enterococci. Microb. Drug Resist. 2:219-223.
9. Goldstein, E. J., and V. L. Sutter. 1983. Effect of carbon dioxide on erythromycin. Antimicrob. Agents Chemother. 23:325-327.
10. Hansen, S. L., P. Swomley, and G. Drusano. 1981. Effect of carbon dioxide and pH on the susceptibility of Bacteroidesfragilis group to erythromycin. Antimicrob. Agents Chemother. 19:335-336.
11. Klare, I., H. Heier, H. Claus, R. Reissbrodt, and W. Witte. 1995. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol. Lett. 125:165-171.
12. Klare, I., H. Heier, H. Claus, G. Böhme, S. Marin, G. Seltmann, R. Hakenbeck, V. Antanassova, and W. Witte. 1995. Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal food stuffs and fecal samples of humans in the community. Microb. Drug Resist. 1:265-272.
13. Linton, A. H., M. H. Hinton, and Z. A. M. Al-Chalaby. 1985. Monitoring for antibiotic resistance in enterococci consequent upon feeding growth promoters active against Gram-positive bacteria. J. Vet. Pharmacol. Ther. 8:62-70.
14. National Committee for Clinical Laboratory Standards. 1997. Approved standard M7-A4. Scheme for preparing dilutions of antimicrobial agents to be used in agar dilution susceptibility tests. Suggested modifications of standard methods for susceptibility testing of some fastidious and special problem bacteria (M100-S7). National Committee for Clinical Laboratory Standards, Wayne, Pa.
15. Nicoletti, G., and S. Stefani. 1995. Enterococci: susceptibility patterns and therapeutic options. Eur. J. Clin. Microbiol. Infect. Dis. 1(Suppl.):33-37.
16. Omura, S., and H. Tanaka. 1984. Production and antimicrobial activity of macrolides, p. 3-35. In S. Omura (ed.), Macrolide antibiotics. Academic Press, Orlando, Fla.
17. Sahm, D. F., C. N. Baker, R. N. Jones, and C. Thornsberry. 1983. Medium-dependent zone size discrepancies associated with susceptibility testing of group D streptococci against various cephalosporins. J. Clin. Microbiol. 18: 858-865.
18. Thal, L. A., J. W. Chow, R. Mahayni, H. Bonilla, M. B. Perri, S. A. Donabedian, J. Silverman, S. Taber, and M. J. Zervos. 1995. Characterization of antimicrobial resistance in enterococci of animal origin. Antimicrob. Agents Chemother. 39:2112-2115.
19. Verklin, R. M., and G. L. Mandell. 1977. Alteration of effectiveness of antibiotics by anaerobiosis. J. Lab. Clin. Med. 89:65-71.
20. Wasielewski, E. V., R. Mushaweck, and E. Schütze. 1966. Moenomycin, a new antibiotic. III. Biological properties, p. 743-748. Antimicrob. Agents Chemother. 1965.
21. Williams, A. M., U. M. Rodrigues, and M. D. Collins. 1991. Intragenic relationships of Enterococci as determined by reverse transcriptase sequencing of small-subunit rRNA. Res. Microbiol. 142:67-74.
22. Woods, G. L., and J. A. Washington. 1995. Antibacterial susceptibility tests: dilution and disk diffusion methods, p. 1327-1341. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.